SCN5A Variant Pathogenicity Index Calculator

Clinical calculation support · Verify results before clinical use

Variant evidence inputs

Enter the available variant-level evidence. This page calculates a legacy educational heuristic, not a clinical classification.

0–9Score range
Choose the sequence-variant consequence. Consequence alone does not determine pathogenicity.
Select the broad evidence level supplied for this exercise. Clinical interpretation requires assay-specific validity and calibrated evidence strength.
Conservation is one computational/evolutionary clue and is not sufficient on its own to classify a variant.
Enter a decimal proportion from 0 to 1 (for example, 0.0001 = 0.01%). Use the appropriate ancestry and allele-count context when reviewing population data.

How to interpret variant evidence

SCN5A encodes the cardiac sodium-channel alpha subunit NaV1.5. Variants in this gene have been associated with several phenotypes, including Brugada syndrome, long-QT syndrome, and dilated cardiomyopathy. The relevance of a variant depends on the specific gene–disease relationship, phenotype, molecular consequence, and the total evidence available.

Why this score is limited

  • The point weights and score bands retained here are a legacy heuristic and are not a validated or published SCN5A variant-classification system.
  • Variant consequence alone does not establish loss of function as a disease mechanism for the specific phenotype or transcript; splice effects and predicted loss-of-function variants require contextual assessment.
  • Functional evidence must be assessed according to the assay, controls, reproducibility, and disease mechanism. “Strong” is not a substitute for applying a formal evidence code.
  • Conservation and population frequency require calibrated thresholds and context. A single generic frequency cutoff cannot classify every SCN5A-associated condition.
  • Formal classification integrates multiple evidence types, which can include population, computational, functional, segregation, de novo, allelic, and phenotype data.

Recommended clinical workflow

For clinical use, document the exact HGVS variant and transcript, phenotype and inheritance context, review current ClinVar and population data, evaluate the relevant ACMG/AMP criteria and SCN5A-specific expert-panel specifications when available, and obtain qualified clinical molecular genetics review. Do not infer patient-level arrhythmic risk from this heuristic score.

References and resources

Richards S, Aziz N, Bale S, et al. (ACMG/AMP). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation. Genetics in Medicine. 2015;17:405–424.
doi:10.1038/gim.2015.30
ClinGen Sodium and Calcium Channel Arrhythmia Variant Curation Expert Panel. The expert panel focuses on rigorous adaptation and application of ACMG/AMP criteria for SCN5A variant interpretation. Consult the panel page for current status and linked specifications.
ClinGen expert panel resource
ClinGen Variant Curation Expert Panel procedures and resources. General resources and procedures for standardized variant curation.
ClinGen curation resources
Clinical disclaimer: This calculator is for educational exploration only and is not a diagnostic device or validated clinical decision-support instrument. It does not provide a clinical variant classification. Variant interpretation should be performed using current evidence and applicable professional standards by qualified genetics professionals and a clinical laboratory. Do not use this score alone for treatment, family testing, or risk prediction.